Baker Bros. Capital (GP), LLC Insider Trading $DDXS Diadexus, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Diadexus, Inc. ($DDXS) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Baker Bros. Capital (GP), LLC in Diadexus, Inc.

Trading Symbol: DDXS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 31 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in Diadexus, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADLR, IBPI, AUXL, BCRX, DDXS, GHDX, HRTX, INCY, SGEN, GEVA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 31 2012DDXSDiadexus, Inc.Baker Bros. Capital (GP), LLC10% OwnerSellS0.2259,34013,156059.3 K to 0 (-100.00 %)
Jan 20 2012DDXSDiadexus, Inc.Baker Bros. Capital (GP), LLC10% OwnerSellS0.2020,0004,00059,34079.3 K to 59.3 K (-25.21 %)
Jan 20 2012DDXSDiadexus, Inc.Baker Bros. Capital (GP), LLC10% OwnerSellS0.21118,80025,23379,340198.1 K to 79.3 K (-59.96 %)

Page:   1